Literature DB >> 9781911

The syndromes of Sotos and Weaver: reports and review.

J M Opitz1, D W Weaver, J F Reynolds.   

Abstract

The syndromes of Sotos and Weaver are paradigmatic of the daily nosologic difficulties faced by clinical geneticists attempting to diagnose and counsel, and to give accurate prognoses in cases of extensive phenotypic overlap between molecularly undefined entities. Vertebrate development is constrained into only very few final or common developmental paths; therefore, no developmental anomaly seen in humans is unique to ("pathognomonic" of) one syndrome. Thus, it is not surprising that prenatal overgrowth occurs in several syndromes, including the Sotos and Weaver syndromes. Are they sufficiently different in other respects to allow the postulation of locus (rather than allele) heterogeneity? Phenotypic data in both conditions are biased because of ascertainment of propositi, and the apparent differences between them may be entirely artificial as they were between the G and BBB syndromes. On the other hand, the Sotos syndrome may be a cancer syndrome, the Weaver syndrome not (though a neuroblastoma was reported in the latter); in the former there is also remarkably advanced dental maturation rarely commented on in the latter. In Weaver syndrome there are more conspicuous contractures and a facial appearance that experts find convincingly different from that of Sotos individuals. Nevertheless, the hypothesis of locus heterogeneity is testable; at the moment we are inclined to favor the hypothesis of allele heterogeneity. An international effort is required to map, isolate, and sequence the causal gene or genes.

Entities:  

Mesh:

Year:  1998        PMID: 9781911     DOI: 10.1002/(sici)1096-8628(19981002)79:4<294::aid-ajmg12>3.0.co;2-m

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  21 in total

1.  NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes.

Authors:  Jenny Douglas; Sandra Hanks; I Karen Temple; Sally Davies; Alexandra Murray; Meena Upadhyaya; Susan Tomkins; Helen E Hughes; Trevor R P Cole; Nazneen Rahman
Journal:  Am J Hum Genet       Date:  2002-12-02       Impact factor: 11.025

Review 2.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

Review 3.  Mendelian disorders of the epigenetic machinery: tipping the balance of chromatin states.

Authors:  Jill A Fahrner; Hans T Bjornsson
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

Review 4.  Overgrowth Syndrome.

Authors:  Yahan Li; Callum G Donnelly; Rocío Melissa Rivera
Journal:  Vet Clin North Am Food Anim Pract       Date:  2019-07       Impact factor: 3.357

5.  Soto's syndrome with bilateral hydronephrosis and hydroureters.

Authors:  Utpal S Bhalala; Pankaj R Parekh; Milind S Tullu
Journal:  Indian J Pediatr       Date:  2002-10       Impact factor: 1.967

6.  Exclusion of progressive brain disorders of childhood for a cerebral palsy monitoring system: a public health perspective.

Authors:  Richard S Olney; Nancy S Doernberg; Marshalyn Yeargin-Allsop
Journal:  J Registry Manag       Date:  2014

Review 7.  Genetic considerations in the prenatal diagnosis of overgrowth syndromes.

Authors:  Neeta Vora; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2009-10       Impact factor: 3.050

8.  Weaver syndrome: A report of a rare genetic syndrome.

Authors:  Nitin Bansal; Amit Bansal
Journal:  Indian J Hum Genet       Date:  2009-01

9.  The first neurosurgical analysis of 8 korean children with sotos syndrome.

Authors:  Jae Joon Lim; Soo Han Yoon
Journal:  J Korean Neurosurg Soc       Date:  2008-10-30

10.  Specific entities affecting the craniocervical region: syndromes affecting the craniocervical junction.

Authors:  Arnold H Menezes; Timothy W Vogel
Journal:  Childs Nerv Syst       Date:  2008-03-28       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.